OUR SERVICES

Need to connect with leading oncologists, clinical genomics experts, or payers in liquid biopsy, genomic profiling, or precision oncology? We identify and engage the right KOLs for your project through our established networks and continuous monitoring of the field.

Gain expert perspectives on clinical trial design for a novel precision therapy, market access strategy for a companion diagnostic or development of a liquid biopsy assay. We help you assemble high-impact advisory boards to provide strategic guidance and validate your approach.

Secure optimal pricing and reimbursement for your novel molecular diagnostics, while taking into account upcoming IVDR in EU and changes to LDTs in USA. We develop compelling Value Dossiers that clearly demonstrate the clinical and economic benefits of your product.

Communicate your research findings effectively, particularly in specialized areas like comprehensive molecular profiling and liquid biopsy. Our expert medical writers ensure your manuscripts are clear, concise, and impactful.

CASE STUDIES

Navigating the Global NGS Oncology Market

Lorem fistrum por la gloria de mi madre esse jarl aliqua llevame al sircoo. De la pradera ullamco qué dise usteer está la cosa muy malar.

Analysis of Biomarker Reimbursement in Oncology

Lorem fistrum por la gloria de mi madre esse jarl aliqua llevame al sircoo. De la pradera ullamco qué dise usteer está la cosa muy malar.

Molecular Diagnostic Reimbursement: A Value Dossier

Lorem fistrum por la gloria de mi madre esse jarl aliqua llevame al sircoo. De la pradera ullamco qué dise usteer está la cosa muy malar.